No Picture
Trading Ideas

Coronavirus: Trump retweets call to fire Fauci

White House spokesman Hogan Gidley says “President Trump is not firing Dr. Fauci,” after President Trump retweeted a call to fire the director of the National Institute of Allergy and Infectious Diseases. Former White House Medical Unit Physician for Obama, Biden and Pence, Dr. Jennifer Pena, joins Yahoo Finance’s Seana Smith to discuss. …read more […]

No Picture
Trading Ideas

Starbucks of China could soon be de-listed over fraud allegations

Shares of Luckin Coffee Inc (NASDAQ:LK) were halted last week for pending news. At the time of this writing, the stock had not resumed trading, and it’s unclear what the pending news is. However, there are some possibilities. Luckin Coffee stock halted: chairman, CEO default On Monday, a press release issued by Goldman Sachs said […] …read more […]

No Picture
Trading Ideas

The Coronavirus Outlook: Better Than Anticipated

Experts have used a variety of data models to predict the impact of COVID-19 on global health and wealth.
But, as Alexander Green explains today, many of those early predictions have been way off.

I keep hearing from readers who think the stock market has lost its mind.
“How can the Dow rally 5,400 points over the last three weeks,” one reader asked, “when the coronavirus and its economic impact are even worse than expected?”
The stock market is a leading indicator. To understand it, you have to look forward, not back.
Second quarter GDP growth is going to be a train wreck, perhaps the …read more […]

No Picture
Business News

U.S. government holding firm on airline aid plan, could end up with 3% of American Airlines

The U.S. Treasury Department is holding firm on the terms of a $25 billion offer for government aid to airlines to help them meet payroll during the coronavirus downturn, officials said on Monday, and the plan could give the government more than 3% of American Airlines Group Inc .

…read more […]

No Picture
Trading Ideas

Is COVID-19 Vaccine Maker Novavax a Buy Right Now? Here’s What You Need to Know

And just like that, Novavax (NVAX) is back in the spotlight. Gaining a whopping 328% since the start of 2020, the healthcare company has consistently attracted attention from market watchers, primarily thanks to its efforts to develop a vaccine against COVID-19. The latest reason for its appearance on Wall Street’s radar? Its vaccine development program’s giant leap forward.On April 8, the company announced that it had identified a lead COVID-19 vaccine candidate. The experimental vaccine, NVX-CoV2373, is a prefusion protein created using NVAX’s patented lipid nanoparticle platform, with a Phase 1 first-in-human study set to begin in mid-May. As a …read more […]